Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C.
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about 3 to 5 million annual cases of severe illness, and about 250,000 to 500,000 annual deaths worldwide. In 2009, a pandemic of influenza A, which spread quickly to many countries, gained the attention of scientists to focus on better diagnosis of the virus.
Initiatives by government bodies such as WHO and CDC to control and prevent influenza are a factor driving the influenza diagnostics market. Furthermore, the growing amount of research and development, technological advancements in diagnostic tests, and rising demand for influenza diagnosis are likely to propel this market during the forecast period. However the increasing prices of kits and reagents may pose a hindrance.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17435
The influenza diagnostics market has been segmented by test type, end-users, and geography. In terms of test type, the divisions include rapid influenza diagnostic tests (RIDT), RT-PCR, cell culture, and others, including serology and immunofluorescence tests. The market share of RIDT has increased considerably due to its ability to provide quick results and recent approvals by the FDA. Based on end-users, the market is split into the following categories: hospitals, research centers, diagnostic laboratories, and point of care testing centers. Currently, hospitals hold a major share in the influenza diagnostics market due to regular epidemics, their easy accessibility, and a generally higher preference for this establishment; however, point of care testing is also likely to develop at a significant rate during the forecast period owing to the ease of usage that the medium offers.
Request for Analysis of COVID19 Impact on Influenza Diagnostics Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=17435
Geographically, the influenza diagnostics market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America constituted a substantial share in the market due to factors such as initiatives by government bodies to control the disease rates, technological advancements, health awareness among population, and research. The market in Asia Pacific is projected to expand rapidly due to its higher disease burden, higher rate of population, and rising initiatives to control the disease rate. For example, the CDC funds non research-related bilateral influenza cooperative agreements in South-East Asia aimed at routine diagnosis of seasonal flu and pandemic influenza.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=17435
Some of the key players in the influenza diagnostics market include Becton Dickinson and Company, Roche Diagnostics, Alere Scarborough, Inc, Princeton BioMedtech corp, Sekisui Diagnostics, SA Scientific, Inc, Quidel Corporation, Meridian Bioscience, Inc, and Thermo Fisher Scientific. These companies focus on introduction of cost-effective products with the ability to deliver quick results. For example, the ‘Alere i’ test to diagnose types A and B of influenza within 15 minutes was cleared for marketing by the FDA in June 2014.
Pre book Influenza Diagnostics Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=17435<ype=S
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/